All lobbying filings

ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for NEURELIS, INC. · Biopharmaceutical company specializing in treatments for neurological conditions.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $40,000.00 income · posted Apr 17, 2025

Official filing document

Bills named in this filing 2

HR 7383
Improving Access to Health Care in Rural and Underserved Areas Act
S 1214
RARE Act

Lobbying activity 1

Health Issues

Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Retaining Access and Restoring Exclusivity (RARE) Act (118th, H.R. 7383 / S. 1214).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.